Answers are grounded in this paper and cite their sources.
BACKGROUND: Wide variations in practice patterns exist for the treatment of chronic anal fissure. OBJECTIVE: To characterize practice patterns and report short-term patient outcomes following botulinum toxin injection v. lateral internal sphincterotomy for treatment of chronic anal fissure within a regional quality collaborative. DESIGN: Prospective, multicenter, registry-based cohort study. SETTING: Fifteen hospitals across New England. PATIENTS: Patients undergoing botulinum toxin or lateral internal sphincterotomy for chronic anal fissure. MAIN OUTCOME MEASURES: Fissure healing, change in continence measured by Vaizey score. RESULTS: A total of 224 patients from 26 surgeons and 5 advanced practice providers were included: 183 (82%) underwent botulinum toxin injection and 41 (18%) underwent lateral internal sphincterotomy. Demographics were similar between groups. Most botulinum injections were performed in the operating room (81.4%) with a median dose of 100 units. Injection technique and concomitant procedures varied. Of all lateral internal sphincterotomy procedures, 90.2% were tailored and 56.1% were performed using an open approach. Mean follow-up was 37 days (SD 23.4). Compared with botulinum injection, lateral internal sphincterotomy was associated with improved fissure healing (46.3 vs 24.0%; p < 0.01), greater pain reduction (70.7 vs 44.8%; p < 0.01), improved bleeding resolution (68.3 vs 44.8%; p = 0.01), and higher patient satisfaction scores (9.2 vs 7.6; p < 0.01). There was no difference in mean difference in preoperative and postoperative Vaizey incontinence scores between the groups (−0.88 vs 0.39, p = 0.11) LIMITATIONS: Short follow-up, reporting bias. CONCLUSIONS: Both treatments improved symptoms; however, lateral internal sphincterotomy was associated with improved fissure healing, greater pain reduction, improved bleeding resolution, and higher patient satisfaction, with no difference in continence on short follow-up. There are significant limitations regarding these results as this was a prospective, multicenter quality collaborative rather than a randomized controlled trial. Nonetheless, this project highlights the potential value of a regional collaborative quality registry in informing real-world practice. (See Video Abstract )
No takes yet. Share an insight, caveat, or question.
Gaetani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: